Company news

Bide Pharmatech Co. Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

(688073)"BIDE PHARMATECH CO., LTD."Report for Q3 2026

October 29, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Conducting Foreign Exchange Hedging Business

October 29, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

October 13, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of Directors

October 13, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executives

October 13, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing

October 12, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Resignation of the Securities Affairs Representative

October 8, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Use of Surplus Raised Funds and Remaining Over-raised Funds to Permanently Supplement Working Capital

September 27, 2026

(688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of New Board of Directors

September 27, 2026

Notice on Convening the 3rd Extraordinary General Meeting in 2026

September 27, 2026

Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding Reduction

September 9, 2026

Announcement on the Vesting Results for the First Vesting Period of the Initial Grant and Reserved Grant under the 2024 Restricted Share Incentive Plan

September 7, 2026

Announcement on Provision for Asset Impairment for the First Half of 2026

August 27, 2026

Announcement on Shareholding Reduction Plan of Shareholder

August 24, 2026

Indicative Announcement on Shareholder's Equity Change Reaching an Integer Multiple of 5%

August 12, 2026

Announcement on Abnormal Fluctuations in Stock Trading

August 10, 2026

Indicative Announcement on the Expiration and Non-Renewal of the Concerted Action Agreement among the Actual Controllers and No Change in the Actual Controllers

August 6, 2026

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

July 16, 2026

Indicative Announcement on Shareholders' Equity Change Reaching the 1% Threshold

July 8, 2026

Announcement on Renewing Engagement of Audit Institution for 2026

June 30, 2026

Announcement on Resignation of Secretary of the Board of Directors

June 17, 2026

Indicative Announcement on Shareholder's Equity Change Reaching 1% Scale

June 12, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 3, 2026

Announcement on Shareholding Reduction Plan for Shareholders

May 18, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 13, 2026

Report for Q1 2026

April 29, 2026

Announcement on Expiration of Shareholding Reduction Plan for Shareholders and Results of Shareholding Reduction

April 28, 2026

Announcement on 2025 Annual Profit Distribution Plan

April 22, 2026

Announcement on Completion of Shareholding Reduction Plan by Shareholder and Results of Share Reduction

April 7, 2026

Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering

April 2, 2026

Announcement on Using Self-owned Funds to Pay Funds Required for Investment Projects Financed by Raised Funds and Replacing Them with an Equal Amount of Raised Funds

March 9, 2026

Announcement on Preliminary Earnings Estimate for 2025

February 27, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

February 9, 2026

Notice on Convening the 1st Extraordinary General Meeting in 2026

January 23, 2026

Announcement on Supplementary Confirmation of Daily Related Party Transactions in 2025

January 5, 2026

Indicative Announcement on Change in Shareholder's Equity Reaching an Integer Multiple of 5%

December 22, 2025

Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025

December 10, 2025

Announcement on the By-election of Non-independent Directors

November 24, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 19, 2025

Indicative Announcement on Shareholder's Equity Change Reaching 1%

November 14, 2025

Report for Q3 2025

October 29, 2025

Announcement on Planning to Conduct Foreign Exchange Hedging Business

October 15, 2025

Announcement on Correction of 2025 Semi-annual Report

September 12, 2025

Announcement on Completing Industrial and Commercial Change and Obtaining Business Licenses

September 2, 2025

Announcement on Making Provisions for Asset Impairment for the Half-Year Period of 2025

August 21, 2025

Announcement on Resignation of Director and Election of Employee Director

August 15, 2025

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025

July 31, 2025

Notice on Convening the 4th Extraordinary General Meeting in 2025

July 15, 2025

Announcement on Adjusting Upper Limit of Repurchase Price after Implementation of Dividend Distribution for 2024

July 2, 2025

Announcement on Progress in Repurchasing Shares

June 4, 2025

Older news releases →